CERT Logo

Certara, Inc. (CERT) 

NASDAQ
Market Cap
$1.89B
Sector
Healthcare
Industry
Medical—Healthcare Information Services
Rank in Sector
600 of 963
Rank in Industry
25 of 43

Largest Insider Buys in Sector

CERT Stock Price History Chart

CERT Stock Performance

About Certara, Inc.

Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. Further, company offers software, comprising mechanistic biosimulation platform, empirical PK/PD biosimulation platform, data standardization and compliance software, scientific informatics platform, clinical outcomes databases for biosimulation, authoring and management of regulatory submissions platform, and market access communication platform. The company serves biopharmaceutical companies, and academic and government institutions. It has operations in the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, Australia, and China. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.

Insider Activity of Certara, Inc.

Over the last 12 months, insiders at Certara, Inc. have bought $0 and sold $1.3M worth of Certara, Inc. stock.

On average, over the past 5 years, insiders at Certara, Inc. have bought $998,243 and sold $691.19M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 4,807 shares for transaction amount of $75,951 was made by BROSHY ERAN (director) on 2023‑08‑22.

List of Insider Buy and Sell Transactions, Certara, Inc.

2024-10-07SalePRESIDENT, DRUG DEV SOLUTIONS
5,409
0.0035%
$11.03$59,661-0.63%
2024-09-09SalePRESIDENT, CHIEF COMMERCAL OFF
51,224
0.0313%
$11.29$578,319-4.01%
2024-04-02SalePRESIDENT, DRUG DEV SOLUTIONS
14,427
0.009%
$16.85$243,161-21.59%
2024-04-01SaleSVP AND GENERAL COUNSEL
3,000
0.0019%
$18.00$54,000-25.97%
2024-03-04SaleSVP AND GENERAL COUNSEL
3,000
0.0018%
$18.28$54,840-21.03%
2024-02-20SalePRESIDENT, DRUG DEV SOLUTIONS
5,000
0.0032%
$18.00$90,000-10.39%
2024-02-12SaleSVP AND GENERAL COUNSEL
6,000
0.0038%
$18.00$108,000-12.58%
2023-12-26SaleSVP AND GENERAL COUNSEL
6,000
0.0037%
$18.00$108,000-11.54%
2023-09-11SalePRESIDENT, CHIEF COMMERCAL OFF
51,224
0.0321%
$14.60$747,870+11.26%
2023-08-22Purchasedirector
4,807
0.003%
$15.80$75,951+3.68%
2023-08-21Purchasedirector
193
0.0001%
$16.10$3,107+0.84%
2023-06-05SalePRESIDENT, INTEGRATED DRUG DEV
19,104
0.0122%
$21.55$411,691-21.90%
2023-05-11SaleSVP AND GENERAL COUNSEL
5,000
0.0031%
$20.82$104,100-19.51%
2023-04-14SaleSVP AND GENERAL COUNSEL
5,000
0.0031%
$23.66$118,300-29.51%
2023-03-06SaleSVP AND GENERAL COUNSEL
10,000
0.0063%
$21.45$214,500-20.08%
2023-02-02SaleSVP AND GENERAL COUNSEL
15,000
0.0094%
$20.00$300,000-13.49%
2022-12-08Saledirector
29.95M
15.9478%
$15.00$449.32M+0.53%
2022-11-22SalePRESIDENT, SOFTWARE
51,223
0.0322%
$15.55$796,518+14.60%
2022-11-15Saledirector
245,793
0.1555%
$15.57$3.83M+15.12%
2022-11-14Saledirector
4,207
0.0028%
$15.27$64,241+22.51%

Insider Historical Profitability

<0.0001%
Traynor Richard M.SVP AND GENERAL COUNSEL
173524
0.1078%
$11.75121<0.0001%
Pedersen Leif EPRESIDENT, CHIEF COMMERCAL OFF
99704
0.0619%
$11.7504
SMITH PATRICK FPRESIDENT, DRUG DEV SOLUTIONS
50091
0.0311%
$11.7508
EQT Fund Management S.a r.l.
29954521
18.6082%
$11.7502
Feehery William FCHIEF EXECUTIVE OFFICER
2178051
1.353%
$11.75015
SLAINE MASON Pdirector
660322
0.4102%
$11.75010
Schemick Michael AndrewCHIEF FINANCIAL OFFICER
517870
0.3217%
$11.7516+7.65%
CASHMAN JAMES E IIIdirector
438782
0.2726%
$11.7512<0.0001%
Edge JustinPRES., REGULATORY & ACCESS
397090
0.2467%
$11.75010
Rayner Craig R.PRESIDENT, INTEGRATED DRUG DEV
316010
0.1963%
$11.7502
Aspbury RobertPRESIDENT, SIMCYP
278969
0.1733%
$11.7506
Choe Jieun W.CHIEF STRATEGY & MARKETING
250491
0.1556%
$11.7507
WALSH MATTHEW Mdirector
167901
0.1043%
$11.7511<0.0001%
McLean Stephen M.
42000
0.0261%
$11.7520<0.0001%
BROSHY ERANdirector
14360
0.0089%
$11.7520
EQT Avatar Parent L.P.director
0
0%
$11.7506

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
BlackRock$250.12M8.713.99M+0.23%+$576,004.200.01
The Vanguard Group$224.49M7.8112.56M+0.09%+$193,461.60<0.01
Baillie Gifford Co$152.65M5.318.54M-4.3%-$6.86M0.12
William Blair Investment Management$102.27M3.565.72M-18.78%-$23.65M0.26
Wasatch Advisors$88.06M3.064.92M+23.36%+$16.67M0.46
Geneva Capital Management LLC$78.75M2.744.4M+15.15%+$10.36M1.39
JPMorgan Chase$77.94M2.714.36M+8.75%+$6.27M0.01
ClearBridge Investments$74.62M2.64.17M+0.79%+$587,286.470.06
State Street$63.61M2.213.56M+1.98%+$1.24M<0.01
Arrowmark Colorado Holdings Llc$63.08M2.193.53M-16.06%-$12.07M0.16
T Rowe Price Investment Management Inc$57.26M1.993.2M+28.64%+$12.75M0.04
Riverbridge Partners$50.39M1.752.82M+0.08%+$38,138.040.62
Dimensional Fund Advisors$50.17M1.752.81M+10.43%+$4.74M0.01
Massachusetts Financial Services Co Ma$45.15M1.572.53M-2.31%-$1.07M0.01
Ameriprise Financial$39.34M1.372.2M-0.25%-$98,179.080.01
Geode Capital Management$33.42M1.161.87M+3.91%+$1.26M<0.01
Franklin Templeton Investments$31.81M1.111.78M-2.3%-$749,708.400.01
London Co Of Virginia$29.09M1.011.63MNew+$29.09M0.15
Royal Bank of Canada$24.63M0.861.38M-2.26%-$570,491.280.01
Northern Trust$22.96M0.81.28M+1.26%+$285,418.43<0.01
Granite Investment Partners Llc$21.69M0.751.21M-0.66%-$143,415.480.82
Bamco$19.42M0.681.09M+1.4%+$268,200.000.05
Morgan Stanley$16.87M0.59943,267+25.61%+$3.44M<0.01
BNY Mellon$14.74M0.51824,639-7.8%-$1.25M<0.01
Rathbone Brothers$13.55M0.47757,590+0.03%+$3,576.000.08
KAYNE ANDERSON INVESTMENT MANAGEMENT LLC$13.36M0.47747,294-0.17%-$22,797.000.03
Bank of America$13.27M0.46741,965+57.06%+$4.82M<0.01
SEI Investments Company$12.79M0.45715,514+12.41%+$1.41M0.02
Charles Schwab$12.29M0.43687,220+8.05%+$915,974.55<0.01
Glenmede$11.95M0.42668,447+8.36%+$921,624.490.06
2Xideas$10.78M0.38602,684-18.94%-$2.52M1.32
Envestnet Asset Management Inc$9.48M0.33530,257+70.66%+$3.93M<0.01
TimesSquare Capital Management LLC$9.3M0.32520,390+2.2%+$200,354.590.14
Daventry Group Lp$9.25M0.32517,1670%+$03.7
Silvercrest Asset Management Group Inc$9.23M0.32516,300+27.27%+$1.98M0.06
Pembroke Management$7.9M0.28441,600-3.24%-$264,516.720.93
Invesco$7.44M0.26416,013-0.27%-$20,401.08<0.01
Mitsubishi UFJ Trust and Banking Corporation$7.34M0.26410,470-14.61%-$1.26M0.02
Scout Investments$6.24M0.22346,750-5.98%-$396,720.000.16
Polar Asset Management Partners Inc$6.15M0.21343,834+34.42%+$1.57M0.12
First Trust$6.07M0.21339,499+0.7%+$42,161.160.01
Nuveen$5.57M0.19311,593-0.85%-$48,061.44<0.01
Legal & General$5.42M0.19303,142-0.32%-$17,629.68<0.01
Fidelity Investments$5.26M0.18294,347+0.06%+$3,146.87<0.0001
RhumbLine Advisers$5.05M0.18282,489-4.12%-$216,864.230.01
Granahan Investment Management$4.1M0.14229,150-5.91%-$257,543.520.14
Swiss National Bank$3.94M0.14220,4000%+$0<0.01
Intrinsic Edge Capital Management Llc$3.93M0.14220,000New+$3.93M0.33
Public Sector Pension Investment Board$3.93M0.14219,520-1.22%-$48,633.610.03
Guggenheim Capital$3.89M0.14217,599+0.78%+$30,181.440.03
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.